A 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine DMF (Drug Master File) is a document detailing the whole manufacturing process of 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine active pharmaceutical ingredient (API) in detail. Different forms of 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine DMFs exist exist since differing nations have different regulations, such as 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine DMF submitted to regulatory agencies in the US is known as a USDMF. 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine USDMF includes data on 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine suppliers with USDMF on PharmaCompass.